This Auto Injectors market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply chain dynamics, and insights about new geographical markets. The market insights covered in Auto Injectors report simplifies managing marketing of goods and services effectively.
The auto injectors market was valued at USD 56.01 billion in 2021 and is expected to reach USD 270.78 billion by 2029, registering a CAGR of 21.77% during the forecast period of 2022-2029.
Download Sample PDF Copy of this Report to understand structure of the complete report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-auto-injectors-market
Market Overview:
Auto injectors are utilized for epinephrine self-administration in order to prevent anaphylaxis, for immediate pain relief by migraine sufferers and for medical and emergency treatments. The rise in incidence of anaphylaxis is escalating the growth of auto injectors market.An auto injector refers to a syringe with a spring-charged needle that has a pre-charged dosage of drugs. A measured dosage of a drug is triggered and administered when pressed into the body with a sliding motion. Auto-injectors offer various advantages such as, reducing needle-related phobia disorder, and risks of needle stuck accidents, among others.
Some of the major players operating in the Auto Injectors market are AbbVie Inc. (US), Mylan N.V. (US), Lily. (US), Amgen Inc. (US), Ypsomed Holding (Switzerland), BD (US), Owen Mumford Ltd. (UK), Consort Medical, Plc. (UK), SHL Medical AG (Switzerland), Johnson Medtech, LLC. (US), Teva Pharmaceuticals USA, Inc. (US), Antares Pharma. (New Jersey), AstraZeneca (UK), Union Medico Inc. (Denmark), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc (US), and Emergent. (US), among others.
Global Auto Injectors Market Scope
The auto injectors market is segmented on the basis of therapy, type, end- users, route of administration, molecule, design and product. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Therapy
Rheumatoid Arthritis
Multiple Sclerosis
Diabetes
Anaphylaxis
Other Therapies
On the basis of therapy, the auto injectors market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis and other therapies.
Type
Disposable Auto Injectors
Reusable Auto Injectors
Auto injectors market on the basis of type is segmented into disposable auto injectors and reusable auto injectors. Reusable auto injector is further divided into prefilled and empty.